Table 1 Characteristics of the studies included in the meta-analysis
Author and publication date | Study date (year, month, day) | Patients (No.) | Age (year) | Severe cases or deaths (%) | Fever (%) | Cough (%) | Lymphopenia (%) | Positive CT findings (%) | Coexisting disorders (%) | Preterm labor (%) | Caesarean section (%) | Fetal distress (%) | Neonatal asphyxia or neonatal death or stillbirth (%) | Neonatal infection (%) | Virus in breast milk (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Breslin N 2020.4.9 [10] | 2020.3.13–2020.3.27 | 43(a) | 26.9 | 14 | 33 | 44 | – | 9 | 42 | – | 19 | – | – | 0 | – |
Chen H 2020.2.12 [11] | 2020.1.20–2020.1.31 | 9 | 29.9 | 0 | 78 | 44 | 56 | 89 | 33 | 44 | 100 | 22 | 0 | 0 | 0 |
Chen R 2020.3.16 [12] | 2020.1.30–2020.2.23 | 17 | 29.4 | 0 | 24 | 24 | 29 | 100 | 47 | 18 | 100 | 0 | 0 | 0 | – |
Chen S 2020.3.28 [13] | 2020.1.20–2020.2.10 | 5 | 28.8 | 0 | 100 | 20 | 80 | 100 | 60 | 0 | 40 | 0 | 0 | – | – |
Khan S 2020.4.8 [14] | 2020.1.25–2020.2.15 | 17 | 29.3 | – | 18 | 35 | 24 | 29 | 29 | 18 | 100 | 0 | 0 | 12 | – |
Li N 2020.3.30 [15] | 2020.1.24–2020.2.29 | 16 | 30.9 | 0 | 25 | 0 | 13 | 94 | 69 | 25 | 88 | 13 | 0 | 0 | – |
Liu D 2020.3.7 [16] | 2020.1.20–2020.2.10 | 15 | 32 | 0 | 87 | 60 | 80 | 100 | 13 | – | 67 | – | 0 | – | – |
Liu H 2020.3.11 [17] | 2020.1.27–2020.2.14 | 16 | 30 | 0 | 44 | 38 | 56 | 81 | 20 | – | – | 0 | 0 | – | – |
Liu Y 2020.2.27 [18] | 2019.12.8–2020.2.25 | 13 | 29.7 | 8 | 77 | 15 | – | – | 8 | 46 | 77 | 23 | 8(b) | 0 | – |
Sutton D 2020.4.13 [19] | 2020.3.22–2020.4.4 | 33(a) | – | – | 21 | – | – | – | – | – | – | – | – | – | – |
Wu X 2020.4.8 [20] | 2019.12.31–2020.3.7 | 23 | 29 | 0 | 17 | 26 | – | 35 | 35 | 13 | 78 | – | 0 | 0 | – |
Yang H 2020.4.12 [21] | 2020.1.20–2020.3.5 | 13 | 30.2 | – | 77 | 15 | – | 92 | – | – | 69 | – | – | 0 | – |
Yu N 2020.3.24 [22] | 2020.1.1–2020.2.8 | 7 | 32 | 0 | 86 | 14 | 71 | 100 | 29 | 0 | 100 | – | 0 | 14 | – |
Zhu H 2020.2 [23] | 2020.1.20–2020.2.5 | 9 | 30 | – | 89 | 44 | – | 100 | 0 | 33 | 78 | 16 | 11(c) | 0 | – |